Alex Moreno joined our company fall of 2018 as an early stage researcher through the European Training Network COSMIC, funded from the European Union´s Horizon 2020 research and innovation program (NO 765158). Since then he has been focusing his research on B cell development and antibody mediated effects in arthritis models with very promising results. We are now happy to have him starting his doctoral education as an industrial PhD student at Redoxis, under supervision of Prof. Rikard Holmdahl at Karolinska Institute, Stockholm. During the next four years Alex will continue his work on evaluating the effect of antibodies in various models of autoimmune arthritis as well as characterise the B cell response in those models in a close collaboration between Redoxis and the research group at KI. .